Copyright
©The Author(s) 2019.
World J Gastroenterol. Nov 7, 2019; 25(41): 6273-6288
Published online Nov 7, 2019. doi: 10.3748/wjg.v25.i41.6273
Published online Nov 7, 2019. doi: 10.3748/wjg.v25.i41.6273
Characteristic | CD (n = 90) | UC (n = 90) | HCs (n = 80) | PCs (n = 35) |
Male/female | 48/42 | 38/52 | 46/34 | 19/16 |
Mean age (yr) | 39.94 ± 11.80 | 41.69 ± 12.40 | 37.64 ± 9.30 | 42.40 ± 10.20 |
Range (yr) | 17-67 | 20-73 | 20-72 | 18-70 |
Tobacco smoking (n) | ||||
Never | 60 | 67 | 50 | 20 |
Past or current use | 30 | 23 | 30 | 15 |
Disease duration (yr) | 5.1 ± 3.1 | 5.1 ± 3.4 | ||
Disease location: CD, n (%) | ||||
L1 | 37 (41.1) | |||
L2 | 20 (22.2) | |||
L3 | 33 (36.7) | |||
Disease activity: CDAI, n (%) | ||||
Remission | 16 (17.8) | |||
Mild | 19 (21.1) | |||
Moderate | 40 (44.4) | |||
Severe | 15 (16.7) | |||
Disease behavior:CD, n (%) | ||||
B1 | 39 (43.3) | |||
B2 | 33 (36.7) | |||
B3 | 18 (20.0) | |||
Disease location: UC, n (%) | ||||
E1 | 36 (40.0) | |||
E2 | 29 (32.2) | |||
E3 | 25 (27.8) | |||
Disease severity, n (%) | ||||
Remission | 14 (15.6) | |||
Mild | 30 (33.3) | |||
Moderate | 31 (34.4) | |||
Severe | 15 (16.7) | |||
Medications, n (%) | ||||
5-ASA | 80 (88.9) | 87 (96.7) | ||
Corticosteroids | 50 (11.7) | 41 (45.5) | ||
Immunosuppressants | 28 (31.1) | 14 (15.6) | ||
Anti-TNF-α | 13 (14.4) | 4 (4.4) | ||
Surgery | 4 (4.4) | 1 (1.1) |
- Citation: Ye YL, Yin J, Hu T, Zhang LP, Wu LY, Pang Z. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients. World J Gastroenterol 2019; 25(41): 6273-6288
- URL: https://www.wjgnet.com/1007-9327/full/v25/i41/6273.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i41.6273